- This event has passed.
BC Provincial Deprescribing Webinar
February 8, 2023 @ 12:00 pm - 1:00 pmFree
- Can I stop any of these?
- Which should I stop first?
- Do I need to taper this drug? If so, how?
- What should I monitor for after stopping, and when?
Many clinicians address these clinical questions successfully, improving outcomes for patients. Sometimes, things don’t work out as we hope. At the Therapeutics Initiative, we want to create a platform for healthcare providers, patients, caregivers, advocates and policy makers to learn from each other about successes and challenges in deprescribing. Learning together, we hope to build confidence and knowledge about deprescribing in BC and beyond.
The February 8, 2023 inaugural BC Provincial Deprescribing Webinars will present 2 cases:
The presenting family doctor writes:
“Do you have patients taking multiple high dose psychiatric medications who are no longer followed by a psychiatrist? Do you feel uncomfortable with their medication regimen and wonder how to safely deprescribe? Dr. Jill Norris (family doctor) and Dr. Alison Gregson (psychiatrist) will present a patient case that addresses some challenges to deprescribing psychiatric medications that family doctors face. The case highlights the potential for rapid deprescribing, ad hoc collaboration with a consulting inpatient psychiatrist, and the contributions of the community pharmacist. We will also discuss benefits and challenges of rapid deprescribing, and ongoing challenges to address this patient’s future mental health.”
Our presenting primary care clinical pharmacist writes:
“Adverse drug effects reported from clinical trials and in drug monographs typically reflect experiences with a single drug, given to reasonably healthy people. In real world clinical practice, our perspective is often very different. What happens when we mix multiple medications with overlapping effects that target many neurotransmitters, in a patient with a complex history? To what do we attribute observed problems that are almost certainly multifactorial? Is there a logical approach to tapering or stopping drugs in this scenario? How, and by whom, are changes initiated and communicated? I hope this case sparks debate on how to approach this complicated challenge constructively.”